|
1
|
Dirx MJ, Zeegers MP, Dagnelie PC, Van den
Bogaard T and Van den Brandt PA: Energy restriction and the risk of
spontaneous mammary tumors in mice: a meta-analysis. Int J Cancer.
106:766–770. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pariza MW: Fat, calories, and mammary
carcinogenesis: net energy effects. Am J Clin Nutr. 45:261–263.
1987.PubMed/NCBI
|
|
3
|
Tucker MJ: The effect of long-term food
restriction on tumours in rodents. Int J Cancer. 23:803–807. 1979.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gillette CA, Zhu Z, Westerlind KC, Melby
CL, Wolfe P and Thompson HJ: Energy availability and mammary
carcinogenesis: effects of calorie restriction and exercise.
Carcinogenesis. 18:1183–1188. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cleary MP, Hu X, Grossmann ME, et al:
Prevention of mammary tumorigenesis by intermittent caloric
restriction: does caloric intake during refeeding modulate the
response? Exp Biol Med. 232:70–80. 2007.PubMed/NCBI
|
|
6
|
Cleary MP, Jacobson MK, Phillips FC,
Getzin SC, Grande JP and Maihle NJ: Weight-cycling decreases
incidence and increases latency of mammary tumors to a greater
extent than does chronic caloric restriction in mouse mammary tumor
virus-transforming growth factor-alpha female mice. Cancer
Epidemiol Biomarkers Prev. 11:836–843. 2002.
|
|
7
|
Thompson HJ, McGinley JN, Spoelstra NS,
Jiang W, Zhu Z and Wolfe P: Effect of dietary energy restriction on
vascular density during mammary carcinogenesis. Cancer Res.
64:5643–5650. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu Z, Jiang W and Thompson HJ: An
experimental paradigm for studying the cellular and molecular
mechanisms of cancer inhibition by energy restriction. Mol
Carcinog. 35:51–56. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Engelman RW, Day NK, Chen RF, et al:
Calorie consumption level influences development of C3H/Ou breast
adenocarcinoma with indifference to calorie source. Proc Soc Exp
Biol Med. 193:23–30. 1990.PubMed/NCBI
|
|
10
|
Carlson JA and Hoelzel F: Apparent
prolongation of the life span of rats by intermittent fasting: one
figure. J Nutr. 31:363–375. 1946.PubMed/NCBI
|
|
11
|
Pape-Ansorge KA, Grande JP, Christensen
TA, Maihle NJ and Cleary MP: Effect of moderate caloric restriction
and/or weight cycling on mammary tumor incidence and latency in
MMTV-Neu female mice. Nutr Cancer. 44:162–168. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hankinson SE and Schernhammer ES:
Insulin-like growth factor and breast cancer risk: evidence from
observational studies. Breast Dis. 17:27–40. 2003.PubMed/NCBI
|
|
13
|
Hartman J, Lindberg K, Morani A, Inzunza
J, Strom A and Gustafsson JA: Estrogen receptor beta inhibits
angiogenesis and growth of T47D breast cancer xenografts. Cancer
Res. 66:11207–11213. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kaaks R: Nutrition, insulin, IGF-1
metabolism and cancer risk: a summary of epidemiological evidence.
Novartis Found Symp. 262:247–260; discussion 260–268. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lukanova A, Lundin E, Zeleniuch-Jacquotte
A, et al: Body mass index, circulating levels of sex-steroid
hormones, IGF-I and IGF-binding protein-3: a cross-sectional study
in healthy women. Eur J Endocrinol. 150:161–171. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen DC, Chung YF, Yeh YT, et al: Serum
adiponectin and leptin levels in Taiwanese breast cancer patients.
Cancer letters. 237:109–114. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nakayama S, Miyoshi Y, Ishihara H and
Noguchi S: Growth-inhibitory effect of adiponectin via adiponectin
receptor 1 on human breast cancer cells through inhibition of
S-phase entry without inducing apoptosis. Breast Cancer Res Treat.
112:405–410. 2008. View Article : Google Scholar
|
|
18
|
Hu X, Juneja SC, Maihle NJ and Cleary MP:
Leptin-a growth factor in normal and malignant breast cells and for
normal mammary gland development. J Natl Cancer Inst. 94:1704–1711.
2002. View Article : Google Scholar
|
|
19
|
Grossmann ME, Nkhata KJ, Mizuno NK, Ray A
and Cleary MP: Effects of adiponectin on breast cancer cell growth
and signaling. Br J Cancer. 98:370–379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ray A, Nkhata KJ and Cleary MP: Effects of
leptin on human breast cancer cell lines in relationship to
estrogen receptor and HER2 status. Int J Oncol. 30:1499–1509.
2007.PubMed/NCBI
|
|
21
|
Vona-Davis L and Rose DP: Adipokines as
endocrine, paracrine, and autocrine factors in breast cancer risk
and progression. Endocr Relat Cancer. 14:189–206. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Korner A, Pazaitou-Panayiotou K, Kelesidis
T, et al: Total and high-molecular-weight adiponectin in breast
cancer: in vitro and in vivo studies. J Clin Endocrinol Metab.
92:1041–1048. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Miyoshi Y, Funahashi T, Kihara S, et al:
Association of serum adiponectin levels with breast cancer risk.
Clin Cancer Res. 9:5699–5704. 2003.PubMed/NCBI
|
|
24
|
Tworoger SS, Eliassen AH, Kelesidis T, et
al: Plasma adiponectin concentrations and risk of incident breast
cancer. J Clin Endocrinol Metab. 92:1510–1516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cleary MP, Juneja SC, Phillips FC, Hu X,
Grande JP and Maihle NJ: Leptin receptor-deficient
MMTV-TGF-alpha/Lepr(db)Lepr(db) female mice do not develop
oncogene-induced mammary tumors. Exp Biol Med. 229:182–193.
2004.PubMed/NCBI
|
|
26
|
Cleary MP, Phillips FC, Getzin SC, et al:
Genetically obese MMTV-TGF-alpha/Lep(ob)Lep(ob) female mice do not
develop mammary tumors. Breast Cancer Res Treat. 77:205–215. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dieudonne MN, Bussiere M, Dos Santos E,
Leneveu MC, Giudicelli Y and Pecquery R: Adiponectin mediates
antiproliferative and apoptotic responses in human MCF7 breast
cancer cells. Biochem Biophys Res Commun. 345:271–279. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dieudonne MN, Machinal-Quelin F,
Serazin-Leroy V, Leneveu MC, Pecquery R and Giudicelli Y: Leptin
mediates a proliferative response in human MCF7 breast cancer
cells. Biochem Biophys Res Commun. 293:622–628. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Grossmann EM, Ray A, Dogan S, Mizuno KN
and Cleary MP: Balance of adiponectin and leptin in relationship to
breast cancer cell growth. Cell Research. (In press).
|
|
30
|
Mistry T, Digby JE, Desai KM and Randeva
HS: Leptin and adiponectin interact in the regulation of prostate
cancer cell growth via modulation of p53 and bcl-2 expression. BJU
Int. 101:1317–1322. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fenton JI, Birmingham JM, Hursting SD and
Hord NG: Adiponectin blocks multiple signaling cascades associated
with leptin-induced cell proliferation in Apc Min/+ colon
epithelial cells. Int J Cancer. 122:2437–2445. 2008.PubMed/NCBI
|
|
32
|
Matsui Y, Halter SA, Holt JT, Hogan BL and
Coffey RJ: Development of mammary hyperplasia and neoplasia in
MMTV-TGF alpha transgenic mice. Cell. 61:1147–1155. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lundy J, Schuss A, Stanick D, McCormack
ES, Kramer S and Sorvillo JM: Expression of neu protein, epidermal
growth factor receptor and transforming growth factor alpha in
breast cancer. Correlation with clinicopathologic parameters. Am J
Pathol. 138:1527–1534. 1991.
|
|
34
|
Murray PA, Barrett-Lee P, Travers M,
Luqmani Y, Powles T and Coombes RC: The prognostic significance of
transforming growth factors in human breast cancer. Br J Cancer.
67:1408–1412. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rajkumar T and Gullick WJ: The type I
growth factor receptors in human breast cancer. Breast Cancer Res
Treat. 29:3–9. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Panico L, D’Antonio A, Salvatore G, et al:
Differential immunohistochemical detection of transforming growth
factor alpha, amphiregulin and CRIPTO in human normal and malignant
breast tissues. Int J Cancer. 65:51–56. 1996. View Article : Google Scholar
|
|
37
|
Reeves PG, Nielsen FH and Fahey GC Jr:
AIN-93 purified diets for laboratory rodents: final report of the
American Institute of Nutrition ad hoc writing committee on the
reformulation of the AIN-76A rodent diet. J Nutr. 123:1939–1951.
1993.PubMed/NCBI
|
|
38
|
Bonorden MJL, Rogozina OP, Kluczny CM,
Grossmann ME, Grambsch PL, Grande JP, Perkins SN, Lokshin A and
Cleary MP: Intermittent calorie restriction delays prostate tumor
detection and increases survival time in TRAMP mice. Nutr Cancer.
61:265–275. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bonorden MJL, Rogozina OP, Kluczny CM,
Grossmann ME, Grande JP, Loshkin A and Cleary MP: Cross-sectional
analysis of intermittent versus chronic caloric restriction in the
TRAMP mouse. Prostate. 69:317–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rogozina OP, Bonorden MJL, Grande JP and
Cleary MP: Serum insulin like growth factor-I and mammary tumor
development in ad libitum-fed, chronic calorie-restricted
and intermittent calorie-restricted MMTV-TGF-α mice. Cancer Prev
Res. 2:712–719. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Silha JV, Weiler HA and Murphy LJ: Plasma
adipokines and body composition in response to modest dietary
manipulations in the mouse. Obesity. 14:1320–1329. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Varady KA, Roohk DJ, Loe YC, McEvoy-Hein
BK and Hellerstein MK: Effects of modified alternate-day fasting
regimens on adipocyte size, triglyceride metabolism, and plasma
adiponectin levels in mice. J Lipid Res. 48:2212–2219. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bluher M, Fasshauer M, Kralisch S, Schon
MR, Krohn K and Paschke R: Regulation of adiponectin receptor R1
and R2 gene expression in adipocytes of C57BL/6 mice. Biochem
Biophys Res Commun. 329:1127–1132. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Barnea M, Shamay A, Stark AH and Madar Z:
A high-fat diet has a tissue-specific effect on adiponectin and
related enzyme expression. Obesity. 14:2145–2153. 2006. View Article : Google Scholar
|
|
45
|
Wang Z, Masternak MM, Al-Regaiey KA and
Bartke A: Adipocytokines and the regulation of lipid metabolism in
growth hormone transgenic and calorie-restricted mice.
Endocrinology. 148:2845–2853. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ryan AS, Nicklas BJ, Berman DM and Elahi
D: Adiponectin levels do not change with moderate dietary induced
weight loss and exercise in obese postmenopausal women. Int J Obes
Relat Metab Disord. 27:1066–1071. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gavrila A, Chan JL, Yiannakouris N, et al:
Serum adiponectin levels are inversely associated with overall and
central fat distribution but are not directly regulated by acute
fasting or leptin administration in humans: cross-sectional and
interventional studies. J Clin Endocrinol Metab. 88:4823–4831.
2003. View Article : Google Scholar
|
|
48
|
Hotta K, Funahashi T, Arita Y, et al:
Plasma concentrations of a novel, adipose-specific protein,
adiponectin in type 2 diabetic patients. Arterioscler Thromb Vasc
Biol. 20:1595–1599. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hulver MW, Zheng D, Tanner CJ, et al:
Adiponectin is not altered with exercise training despite enhanced
insulin action. Am J Physiol Endocrinol Metab. 283:E861–E865. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yang WS, Lee WJ, Funahashi T, et al:
Weight reduction increases plasma levels of an adipose-derived
anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab.
86:3815–3819. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Weiss EP, Racette SB, Villareal DT, et al:
Improvements in glucose tolerance and insulin action induced by
increasing energy expenditure or decreasing energy intake: a
randomized controlled trial. Am J Clin Nutr. 84:1033–1042.
2006.
|
|
52
|
Zhang Y, Matheny M, Zolotukhin S, Tumer N
and Scarpace PJ: Regulation of adiponectin and leptin gene
expression in white and brown adipose tissues: influence of
beta3-adrenergic agonists, retinoic acid, leptin and fasting.
Biochim Biophys Acta. 1584:115–122. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Grossmann ME, Ray A, Dogan S, Mizuno NK
and Cleary MP: Balance of adiponectin and leptin in relationship to
breast cancer cell growth. Cell Res. 18:1154–1156. 2008. View Article : Google Scholar
|
|
54
|
Nkhata KJ, Ray A, Dogan S, Grande JP and
Cleary MP: Mammary tumor development from T47-D human breast cancer
cells in obese ovariectomized mice with and without estradiol
supplements. Breast Cancer Res Treat. 114:71–83. 2009. View Article : Google Scholar
|
|
55
|
Matsubara M, Maruoka S and Katayose S:
Inverse relationship between plasma adiponectin and leptin
concentrations in normal-weight and obese women. Eur J Endocrinol.
147:173–180. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Cnop M, Havel PJ, Utzschneider KM, et al:
Relationship of adiponectin to body fat distribution, insulin
sensitivity and plasma lipoproteins: evidence for independent roles
of age and sex. Diabetologia. 46:459–469. 2003.PubMed/NCBI
|
|
57
|
Vendrell J, Broch M, Vilarrasa N, et al:
Resistin, adiponectin, ghrelin, leptin, and proinflammatory
cytokines: relationships in obesity. Obes Res. 12:962–971. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Anderlova K, Kremen J, Dolezalova R, et
al: The influence of very-low-calorie-diet on serum leptin, soluble
leptin receptor, adiponectin and resistin levels in obese women.
Physiol Res. 55:277–283. 2006.PubMed/NCBI
|
|
59
|
Cleary MP, Grande JP, Juneja SC and Maihle
NJ: Diet-induced obesity and mammary tumor development in MMTV-neu
female mice. Nutr Cancer. 50:174–180. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ray A, Nkhata KJ, Grande JP and Cleary MP:
Diet-induced obesity and mammary tumor development in relation to
estrogen receptor status. Cancer Lett. 253:291–300. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Dogan S, Hu X, Zhang Y, Maihle NJ, Grande
JP and Cleary MP: Effects of high fat diet and/or body weight on
mammary tumor leptin and apoptosis signaling pathways in
MMTV-TGF-alpha mice. Breast Cancer Res. 9:R912007. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Ostlund RE Jr, Yang JW, Klein S and
Gingerich R: Relation between plasma leptin concentration and body
fat, gender, diet, age and metabolic covariates. J Clin Endocrinol
Metab. 81:3909–3913. 1996.PubMed/NCBI
|
